Standout Papers
Citation Impact
Citing Papers
Randomised trial of addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens for patients with HIV-1 infection: the CAESAR trial
1997
Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women
2010 StandoutScience
High Coverage of ART Associated with Decline in Risk of HIV Acquisition in Rural KwaZulu-Natal, South Africa
2013 StandoutScience
HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype
2007 StandoutNobel
A sex-biased imbalance between Tfr, Tph, and atypical B cells determines antibody responses in COVID-19 patients
2023 StandoutNobel
Mouse models of acute and chronic hepacivirus infection
2017 StandoutScienceNobel
A RANDOMISED, DOUBLE‐BLIND STUDY OF ITRACONAZOLE VERSUS PLACEBO IN THE TREATMENT AND PREVENTION OF ORAL OR OESOPHAGEAL CANDIDOSIS IN PATIENTS WITH HIV INFECTION
1999
Characterization of mutation spectra with ultra-deep pyrosequencing: Application to HIV-1 drug resistance
2007
Disease progression in macaques with low SIV replication levels: on the relevance of TREC counts
2005
The Impact of the New WHO Antiretroviral Treatment Guidelines on HIV Epidemic Dynamics and Cost in South Africa
2011
Roles of the ankyrin repeats and C-terminal region of the mouse Notch1 intracellular region
1998 StandoutNobel
A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic Millimeter
1996
A randomized trial of continuous or intermittent therapy with fluconazole for oropharyngeal candidiasis in HIV-infected patients: clinical outcomes and development of fluconazole resistance
1998
Increased production of IL-7 accompanies HIV-1–mediated T-cell depletion: implications for T-cell homeostasis
2001
Atazanavir plus low-dose ritonavir in pregnancy: pharmacokinetics and placental transfer
2007
Differential susceptibility of human thymic dendritic cell subsets to X4 and R5 HIV-1 infection
2006 StandoutNobel
Rethinking amide bond synthesis
2011 StandoutNature
A Randomized, Double‐Blind Comparison of Itraconazole Oral Solution and Fluconazole Tablets in the Treatment of Esophageal Candidiasis
1997
Treatment of Fluconazole-Refractory Oropharyngeal Candidiasis with Itraconazole Oral Solution in HIV-Positive Patients
1999
A Randomized Trial Comparing Fluconazole with Clotrimazole Troches for the Prevention of Fungal Infections in Patients with Advanced Human Immunodeficiency Virus Infection
1995
Management of Hepatic Complications in HIV‐Infected Persons
2008
The search for the CD8+ cell anti-HIV factor (CAF)
2003
Atomic structure of the ectodomain from HIV-1 gp41
1997 StandoutNature
The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry
1996 StandoutNature
Asymptomatic HIV infection is characterized by rapid turnover of HIV RNA in plasma and lymph nodes but not of latently infected lymph-node CD4+ T cells
1997
Viral Protein R Regulates Docking of the HIV-1 Preintegration Complex to the Nuclear Pore Complex
1998 StandoutNobel
A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less
1997 Standout
Better Adherence with Once‐Daily Antiretroviral Regimens: A Meta‐Analysis
2009
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
1997 Standout
Discordant Increases in CD4+T Cells in Human Immunodeficiency Virus–Infected Patients Experiencing Virologic Treatment Failure: Role of Changes in Thymic Output and T Cell Death
2001
Iterative In Situ Click Chemistry Creates Antibody‐like Protein‐Capture Agents
2009 StandoutNobel
Treatment for Adult HIV Infection
2006
HIV-1 Genome Nuclear Import Is Mediated by a Central DNA Flap
2000 StandoutNobel
Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients: pooled 48 week analysis of two randomized, controlled trials
2009
Fluconazole vs Itraconazole-Flucytosine Association in the Treatment of Esophageal Candidiasis in AIDS Patients
1996
Risk compensation: the Achilles' heel of innovations in HIV prevention?
2006
The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial
2006
Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection
1998 Standout
A Randomized, Double‐Blind, Double‐Dummy, Multicenter Trial of Voriconazole and Fluconazole in the Treatment of Esophageal Candidiasis in Immunocompromised Patients
2001
Host factors in the pathogenesis of HIV disease
1997
Type 1/Type 2 Immunity in Infectious Diseases
2001
Refractory Mucosal Candidiasis in Patients with Human Immunodeficiency Virus Infection
1998
Immune Memory and Exhaustion: Clinically Relevant Lessons from the LCMV Model
2015
Recent developments in HIV and the kidney
2008
DADA2: High-resolution sample inference from Illumina amplicon data
2016 Standout
HIV as the cause of AIDS
1996 StandoutNobel
Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function
2001
The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years
2007
Antifungal activity of a new triazole, D0870, compared with four other antifungal agents tested against clinical isolates of Candida and Torulopsis glabrata
1994
Effect of cytokines on HIV-induced depletion of thymocytes in vivo
2000
Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells
1996
Inhibitors of HIV‐1 Protease by Using In Situ Click Chemistry
2006 StandoutNobel
Itraconazole Prophylaxis for Fungal Infections in Patients with Advanced Human Immunodeficiency Virus Infection: Randomized, Placebo‐Controlled, Double‐Blind Study
1999
Psychological and cognitive function: Predictors of adherence with cholesterol lowering treatment
2004
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Molecular and cellular insights into T cell exhaustion
2015 Standout
Synthetic therapeutic peptides: science and market
2009
Racial Differences in End-Stage Renal Disease Rates in HIV Infection versus Diabetes
2007
HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
1996 StandoutNature
Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy
2009
Effect of Immunization with a Common Recall Antigen on Viral Expression in Patients Infected with Human Immunodeficiency Virus Type 1
1996
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
2011 Standout
Impacts of biodiversity on the emergence and transmission of infectious diseases
2010 StandoutNature
Outcomes of Nevirapine- and Efavirenz-Based Antiretroviral Therapy When Coadministered With Rifampicin-Based Antitubercular Therapy
2008
Adherence to Medication
2005 Standout
T Cell Homeostasis
2001
Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure
1997
Kinetics of Response in Lymphoid Tissues to Antiretroviral Therapy of HIV-1 Infection
1997 Science
Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture
1991
HIV Population Dynamics in Vivo: Implications for Genetic Variation, Pathogenesis, and Therapy
1995 StandoutScience
Structure of the HIV-1 gp41 Membrane-Proximal Ectodomain Region in a Putative Prefusion Conformation,
2009
Therapeutic drug monitoring of antiretrovirals for people with HIV
2009
Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages
1999 StandoutNobel
Inhibitors of HIV‐1 Protease by Using In Situ Click Chemistry
2006 StandoutNobel
Fungal Infections of the Genitourinary System
1993
Current and Emerging Azole Antifungal Agents
1999 Standout
Antiretroviral adherence interventions: a review of current literature and ongoing studies.
2004
A molecular clasp in the human immunodeficiency virus (HIV) type 1 TM protein determines the anti-HIV activity of gp41 derivatives: implication for viral fusion
1995
Iterative in Situ Click Chemistry Assembles a Branched Capture Agent and Allosteric Inhibitor for Akt1
2011 StandoutNobel
Generation of Candidate Ligands for Nicotinic Acetylcholine Receptors via in situ Click Chemistry with a Soluble Acetylcholine Binding Protein Template
2012 StandoutNobel
IL-7 Induces Immunological Improvement in SIV-Infected Rhesus Macaques under Antiviral Therapy
2006 StandoutNobel
Observation of the controlled assembly of preclick components in the in situ click chemistry generation of a chitinase inhibitor
2013 StandoutNobel
Positive Effects of Combined Antiretroviral Therapy on CD4 + T Cell Homeostasis and Function in Advanced HIV Disease
1997 StandoutScience
Interleukin-7 and infection itself by human immunodeficiency virus 1 favor virus persistence in mature CD4+CD8−CD3+ thymocytes through sustained induction of Bcl-2
2001 StandoutNobel
Patterns of in vitro activity of itraconazole and imidazole antifungal agents against Candida albicans with decreased susceptibility to fluconazole from Spain
1995
Pathogenesis of human immunodeficiency virus infection
1993
HIV monotherapy with ritonavir-boosted protease inhibitors: a systematic review
2009
Avian diversity and West Nile virus: testing associations between biodiversity and infectious disease risk
2005
Clinical Correlates of Antifungal Macrodilution Susceptibility Test Results for Non-AIDS Patients with Severe Candida Infections Treated with Fluconazole
2000
Guidelines for the Management of Chronic Kidney Disease in HIV-Infected Patients: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America
2005
Vigorous HIV-1-Specific CD4 + T Cell Responses Associated with Control of Viremia
1997 StandoutScience
Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group
1995
Antiretroviral drugs and liver injury
2008
CD8+ T cells suppress human immunodeficiency virus replication by inhibiting viral transcription.
1995
Primary Care Guidelines for the Management of Persons Infected with Human Immunodeficiency Virus: 2009 Update by the HIV Medicine Association of the Infectious Diseases Society of America
2009
Fcγ Receptor-Mediated Suppression of Human Immunodeficiency Virus Type 1 Replication in Primary Human Macrophages
2003 StandoutNobel
Randomized, Double-Blind, Multicenter Study of Caspofungin versus Amphotericin B for Treatment of Oropharyngeal and Esophageal Candidiases
2002
Recovery of Replication-Competent HIV Despite Prolonged Suppression of Plasma Viremia
1997 StandoutScience
Association of Saquinavir Plasma Concentrations with Side Effects but Not with Antiretroviral Outcome in Patients Infected with Protease Inhibitor-Susceptible Human Immunodeficiency Virus Type 1
2007
Disrupting T-cell homeostasis: how HIV-1 infection causes disease.
2004
Positive Regulation of CXCR4 Expression and Signaling by Interleukin-7 in CD4+Mature Thymocytes Correlates with Their Capacity To Favor Human Immunodeficiency X4 Virus Replication
2003 StandoutNobel
Guidelines for Treatment of Candidiasis
2004 Standout
The Long-Term Stability of the Human Gut Microbiota
2013 StandoutScience
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
1996 StandoutScience
Polysialic acid governs T-cell development by regulating progenitor access to the thymus
2009 StandoutNobel
Accurate sampling and deep sequencing of the HIV-1 protease gene using a Primer ID
2011
Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy
1997 StandoutScience
Update on Tick-Borne Rickettsioses around the World: a Geographic Approach
2013 Standout
Rapid Discovery and Structure−Activity Profiling of Novel Inhibitors of Human Immunodeficiency Virus Type 1 Protease Enabled by the Copper(I)-Catalyzed Synthesis of 1,2,3-Triazoles and Their Further Functionalization
2006 StandoutNobel
Cu-Catalyzed Azide−Alkyne Cycloaddition
2008 StandoutNobel
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans
1995 Standout
The microbial mimic poly IC induces durable and protective CD4+T cell immunity together with a dendritic cell targeted vaccine
2008 StandoutNobel
Elicitation of structure-specific antibodies by epitope scaffolds
2010 StandoutNobel
De novo design of protein logic gates
2020 StandoutScienceNobel
Wild type GAL4 binds cooperatively to the GAL1-10 UASG in vitro
1993
Productive human immunodeficiency virus type 1 (HIV-1) infection of nonproliferating human monocytes.
1991
Works of John Bartlett being referenced
Highly active antiretroviral therapy and sexual risk behavior: A metaanalytic review
2004
West nile virus activity-United States, November 13-19, 2003
2004
Recommendations for use of antiretroviral drugs in pregnant hiv-1-infected women for maternal health and interventions to reduce perinatal hiv-1 transmission in the United States
2004
Thymopoiesis in HIV-Infected Adults after Highly Active Antiretroviral Therapy
2001
Effect of Simultaneous Didanosine Administration on Itraconazole Absorption in Healthy Volunteers
1994
CD8 + T Lymphocyte-Mediated Inhibition of HIV-1 Long Terminal Repeat Transcription: A Novel Antiviral Mechanism
1993
Pharmacogenetics of Nevirapine-Associated Hepatotoxicity: An Adult AIDS Clinical Trials Group Collaboration
2006
Minimizing Resistance Consequences After Virologic Failure on Initial Combination Therapy
2006
Manifestations of Pulmonary Cryptococcusis in Patients with Acquired Immunodeficiency Syndrome
1990
Addressing the Challenges of Adherence
2002
Coadministration of Zidovudine and Interleukin‐2 Increases Absolute CD4 Cells in Subjects with Walter Reed Stage 2 Human Immunodeficiency Virus Infection: Results of ACTG Protocol 042
1998
Analysis of the adult thymus in reconstitution of T lymphocytes in HIV-1 infection
1999
Severe Hepatotoxicity Associated with Nevirapine Use in HIV‐Infected Subjects
2005
Successes, challenges, and limitations of current antiretroviral therapy in low-income and middle-income countries
2009
Predictors of proteinuria and renal failure among women with HIV infection
2002
Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adults
2001
An updated systematic overview of triple combination therapy in antiretroviral-naive HIV-infected adults
2006
Reductions in HIV-1 disease progression for zidovudine/lamivudine relative to control treatments
1997
Antiretroviral Monotherapy in Early Stage Human Immunodeficiency Virus Disease Has No Detectable Effect on Virus Load in Peripheral Blood and Lymph Nodes
1996
The sequence of the reovirus serotype 3 L3 genome segment which encodes the major core protein λ1
1988
Detection of minor drug-resistant populations by parallel allele-specific sequencing
2007
Short‐Term Safety and Antiretroviral Activity of T‐1249, a Second‐Generation Fusion Inhibitor of HIV
2004
Long-Term Results of Initial Therapy With Abacavir and Lamivudine Combined With Efavirenz, Amprenavir/Ritonavir, or Stavudine
2006
Protease inhibitors are associated with a slowed progression of HIV-related renal diseases
2002
Oropharyngeal yeast flora and fluconazole resistance in HIV-infected patientsreceiving long-term continuous versus intermitent fluconazole therapy
1996
Analysis of the adult thymus in reconstitution of T lymphocytes in HIV-1 infection
1999
Pharmacokinetics of lamivudine in human immunodeficiency virus-infected patients with renal dysfunction
1996
Decreased human immunodeficiency virus type 1 plasma viremia during antiretroviral therapy reflects downregulation of viral replication in lymphoid tissue.
1995
Lamivudine Plus Zidovudine Compared with Zalcitabine Plus Zidovudine in Patients with HIV Infection
1996
Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1
1993
Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects
2001
Lack of enhancing effect of human anti-human immunodeficiency virus type 1 (HIV-1) antibody on HIV-1 infection of human blood monocytes and peritoneal macrophages
1991
Q Fever, Spotted Fever Group, and Typhus Group Rickettsioses Among Hospitalized Febrile Patients in Northern Tanzania
2011
HIV-1 RNA levels and the development of clinical disease
1996
Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. Humoral and cellular defects.
1990